Our team includes pioneers in genome editing and leaders in cell and gene therapy who are committed to solving significant medical problems. LeadershipBoard of DirectorsScientific Advisors Michael AmorosoPresident, Chief Executive Officer Jeff Smith, Ph.D.Chief Research Officer Cindy AtwellChief Business Officer Alex KellyChief Financial Officer Dario ScimecaGeneral Counsel Cassie Gorsuch, Ph.DHead of Gene Discovery Therapy Neil LeatherburySenior Vice President of Chemistry, Manufacturing, and Controls (CMC) Murray Abramson, MD, MPHSenior Vice President, Head of Clinical Development Juli BlancheChief People Officer Naresh TannaChief of Staff to CEO and Head of Investor Relations Kevin Buehler Michael AmorosoPresident, Chief Executive Officer Melinda Brown Stanley Frankel, M.D. Geno Germano Shari Lisa Piré, J.D. Sam Wadsworth, Ph.D. Raymond Schinazi, Ph.D., DScHepatitis B Advisor Professor Mark Sulkowski, M.D.Hepatitis B Advisor Jordan Feld M.D., MPH, FAASLDHepatitis B Advisor Alan List, M.D.Scientific Advisor
